Skip to main content
letter
. 2021 Jun 30;30:63–66. doi: 10.1016/j.euros.2021.06.007

Fig. 1.

Fig. 1

Percentage change in PSMA SUVmax in biopsied metastases after [177Lu]-PSMA-617 therapy for individual patients. Blue bars = lesion responded; brown bars = lesion stable; yellow bars = lesion progressed according to Positron Emission Tomography Response Criteria in Solid Tumors. The x-axis shows the individual patients with the number above the colums describing the PSMA protein expression assessed by immunohistochemistry of the investigated lesion at baseline.

PSMA = prostate-specific membrane antigen; SUVmax = maximum standardized uptake value on [68Ga]-PSMA positron emission tomography imaging.